IP Library Granted Patent US 11,104,943
Granted Patent B2
US 11,104,943 · App. 16/167,030 · Granted Aug 31, 2021

Methods for processing nucleic acid samples

Inventors: Arkadiusz Bibillo (Cupertino, CA); Pranav Patel (Freemont, CA)
Assignee: Bio-Rad Laboratories, Inc.
C12Q1/686C12N9/1276C12N15/1096C12P19/34C12Q1/68C12Q1/6806C12Q1/6846C12Q2600/112C12Q2600/118C12Q2600/158C12Q2600/16C12Q2600/178C12Y207/07049
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,104,943
App. No.
16/167,030
Granted
Aug 31, 2021
Kind
B2
Abstract

The present disclosure provides methods and systems for amplifying and analyzing nucleic acid samples. The present disclosure provides methods for preparing cDNA and/or DNA molecules and cDNA and/or DNA libraries using modified reverse transcriptases.

Claims (35)

1. A method for preparing a plurality of complementary deoxyribonucleic acid molecule comprising:

(a) depleting at least one ribosomal RNA from a sample comprising a template nucleic acid molecule;

(b) annealing a primer to said template nucleic acid molecule, thereby generating an annealed template nucleic acid molecule; and

(c) mixing, in presence of nucleotides, (i) said annealed template nucleic acid molecule, (ii) one or more acceptor nucleic acid molecules, (iii) a reverse transcriptase, under conditions sufficient to conduct one or more reactions to generate a plurality of complementary deoxyribonucleic acid molecules, wherein said one or more reactions comprise: 1) reverse transcribing a sequence of said annealed template nucleic acid molecule; 2) migrating to an acceptor nucleic acid molecule; and 3) reverse transcribing a sequence of said acceptor nucleic acid molecule, at a temperature of from about 12° C. to about 42° C. at an error rate of at most about 5% as measured by a number of nucleic acid bases that are misincorporated during said one or more reactions.

2. The method of claim 1 , wherein said migrating is independent of sequence identity between said template nucleic acid molecule and said acceptor nucleic acid molecule.

3. The method of claim 1 , wherein (a)-(c) are performed in a single vessel.

4. The method of claim 1 , wherein (a)-(c) are performed in absence of nucleic acid purification.

5. The method of claim 1 , wherein said plurality of complementary deoxyribonucleic acid molecules is prepared in a time period of at most about 3 hours.

6. The method of claim 1 , wherein said reverse transcriptase amplifies said annealed template nucleic acid molecule at a processivity of at least about 80% per nucleic acid base.

7. The method of claim 1 , wherein said reverse transcriptase is configured to prepare at least one complementary deoxyribonucleic acid molecule of said plurality of complementary deoxyribonucleic acid molecules with a performance index greater than 1.0 for at least one enzyme property selected from the group consisting of processivity and stability as compared to a purified enzyme of SEQ ID NO: 52.

8. The method of claim 7 , wherein said reverse transcriptase is an R2 reverse transcriptase.

9. The method of claim 8 , wherein said R2 reverse transcriptase is an R2 non-long terminal repeat retrotransposon enzyme.

10. The method of claim 1 , wherein said reverse transcriptase has at least 80% identity to SEQ ID NO: 49, SEQ ID NO: 50, SEQ ID NO: 51, SEQ ID NO: 53, SEQ ID NO: 54, SEQ ID NO: 55, SEQ ID NO: 56, SEQ ID NO: 57, SEQ ID NO: 58, SEQ ID NO: 59, SEQ ID NO: 60, SEQ ID NO: 61, SEQ ID NO: 62, SEQ ID NO: 63, SEQ ID NO: 64, SEQ ID NO: 65, SEQ ID NO: 66, or SEQ ID NO: 67 and contains at least one substitution modification relative to SEQ ID NO: 52.

11. The method of claim 1 , wherein said plurality of complementary deoxyribonucleic acid molecules comprise detectable tags.

12. The method of claim 1 , further comprising, in (c), performing a polymerase chain reaction (PCR) amplification on a complementary deoxyribonucleic acid molecule generated by said reverse transcriptase, thereby forming one or more amplicons of said complementary deoxyribonucleic acid molecule.

13. The method of claim 12 , wherein (a)-(c) are performed in a same vessel.

14. The method of claim 1 , wherein said sample is a tissue sample.

15. The method of claim 1 , wherein said sample comprises one or more cell free nucleic acids.

16. A method for preparing a plurality of complementary deoxyribonucleic acid molecule comprising:

(a) annealing one or more primers to one or more template nucleic acid molecules derived from a single cell to generate one or more annealed template nucleic acid molecules; and

(b) mixing, in presence of nucleotides, (i) said one or more annealed template nucleic acid molecules, (ii) one or more acceptor nucleic acid molecules, (iii) a reverse transcriptase, under conditions sufficient to conduct one or more reactions to generate a plurality of complementary deoxyribonucleic acid molecules, wherein said one or more reactions comprise reverse transcribing a sequence of an annealed template nucleic acid molecule of said one or more annealed template nucleic acid molecules, migrating to an acceptor nucleic acid molecule, and reverse transcribing a sequence of said acceptor nucleic acid molecule, in a single reaction vessel at room temperature.

17. The method of claim 16 , wherein (a) and (b) are performed on up to about 100 nM of said one or more template nucleic acid molecules.

18. The method of claim 16 , wherein said migration is independent of sequence identity between the template and the acceptor nucleic acid molecule.

19. The method of claim 16 , wherein said plurality of complementary deoxyribonucleic acid molecules are prepared in a time period of at most about 3 hours in said single reaction vessel.

20. The method of claim 16 , wherein said one or more template nucleic acid molecules are selected from the group consisting of an artificially fragmented deoxyribonucleic acid template, a naturally fragmented deoxyribonucleic acid template, an artificially fragmented ribonucleic acid template, a naturally fragmented ribonucleic acid template, and a combination thereof.

21. The method of claim 16 , wherein said reverse transcriptase comprises at least one improved enzyme property relative to a wild type reverse transcriptase.

22. The method of claim 21 , wherein said at least one improved enzyme property is selected from the group consisting of: thermal stability, specific activity, processivity, strand displacement, end-to-end template jumping, affinity, and fidelity.

23. The method of claim 16 , wherein said reverse transcriptase is an R2 reverse transcriptase.

24. The method of claim 16 , wherein said reverse transcriptase has at least 80% identity to SEQ ID NO: 49, SEQ ID NO: 50, SEQ ID NO: 51, SEQ ID NO: 53, SEQ ID NO: 54, SEQ ID NO: 55, SEQ ID NO: 56, SEQ ID NO: 57, SEQ ID NO: 58, SEQ ID NO: 59, SEQ ID NO: 60, SEQ ID NO: 61, SEQ ID NO: 62, SEQ ID NO: 63, SEQ ID NO: 64, SEQ ID NO: 65, SEQ ID NO: 66, or SEQ ID NO: 67 and contains at least one substitution modification relative to SEQ ID NO:52.

25. The method of claim 16 , wherein said plurality of complementary deoxyribonucleic acid molecules comprise detectable tags.

26. The method of claim 16 , further comprising sequencing said plurality of complementary deoxyribonucleic acid molecules.

27. The method of claim 16 , further comprising depleting at least one ribonucleic acid from said one or more template nucleic acid molecules prior to annealing one or more primers.

28. The method of claim 27 , wherein depleting said at least one ribonucleic acid comprises performing an oligonucleotide probe-guided endonucleolitic cleavage of said ribonucleic acid.

29. The method of claim 16 , wherein said one or more primers comprise one or more random primer(s).

30. The method of claim 16 , wherein said one or more primers hybridize to one or more adapter sequences of said one or more template nucleic acid molecules.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2019
From: 2D GENOMICS INC.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 049078/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2018
From: BIBILLO, ARKADIUSZ; PATEL, PRANAV
To: 2D GENOMICS INC.
Reel/Frame 047371/0362 →
Continuity (4)
Continuation PCTUS2017061197 · Nov 10, 2017
Provisional Application 62477211 · Mar 27, 2017
Provisional Application 62421028 · Nov 11, 2016
Related Publication 20190071711A1 · Mar 7, 2019